Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?

Literature DB >> 33283779

Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?

Francesco Ferrara¹, Raffaele La Porta², Priscilla Santilli¹, Vilma D'Aiuto¹, Antonio Vitiello¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Immunosuppressive Agents

Year: 2020 PMID： 33283779 PMCID： PMC8025773 DOI： 10.4103/ijp.IJP_417_20

Source DB: PubMed Journal: Indian J Pharmacol ISSN： 0253-7613 Impact factor: 1.200

× No keyword cloud information.

4 in total

1. Sacubitril, valsartan and SARS-CoV-2.

Authors: Antonio Vitiello; Raffaele La Porta; Francesco Ferrara
Journal: BMJ Evid Based Med Date: 2020-07-27

2. Infection-related health care utilization among people with and without multiple sclerosis.

Authors: José Ma Wijnands; Elaine Kingwell; Feng Zhu; Yinshan Zhao; John D Fisk; Charity Evans; Ruth Ann Marrie; Helen Tremlett
Journal: Mult Scler Date: 2016-12-21 Impact factor: 6.312

Review 3. The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?

Authors: Francesco Ferrara; Giovanni Granata; Chiara Pelliccia; Raffaele La Porta; Antonio Vitiello
Journal: Eur J Clin Pharmacol Date: 2020-06-27 Impact factor: 2.953

4. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?

Authors: Antonio Vitiello; Francesco Ferrara
Journal: Eur J Pharmacol Date: 2020-07-15 Impact factor: 4.432

4 in total

10 in total

Review 1. The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced.

Authors: Antonio Vitiello; Raffaele La Porta; Vilma D'Aiuto; Francesco Ferrara
Journal: Egypt Liver J Date: 2021-01-27

2. Efficacy of synthetic glucocorticoids in COVID-19 endothelites.

Authors: Francesco Ferrara; Antonio Vitiello
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2021-01-14 Impact factor: 3.000

3. Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients.

Authors: Antonio Vitiello; Francesco Ferrara
Journal: Wien Klin Wochenschr Date: 2021-04-20 Impact factor: 2.275

Review 4. The advantages of drug treatment with statins in patients with SARS-CoV-2 infection.

Authors: Francesco Ferrara; Antonio Vitiello
Journal: Wien Klin Wochenschr Date: 2021-03-29 Impact factor: 1.704

Review 5. Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection.

Authors: Antonio Vitiello; Francesco Ferrara
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2021-10-20 Impact factor: 3.000

Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?

1. Sacubitril, valsartan and SARS-CoV-2.

2. Infection-related health care utilization among people with and without multiple sclerosis.

Review 3. The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?

4. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?

Review 1. The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced.

2. Efficacy of synthetic glucocorticoids in COVID-19 endothelites.

3. Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients.

Review 4. The advantages of drug treatment with statins in patients with SARS-CoV-2 infection.

Review 5. Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection.

6. Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection.

Review 7. Pregnancy and COVID-19, focus on vaccine and pharmacological treatment.

Review 8. Plausible Positive Effects of Statins in COVID-19 Patient.

9. Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients.

10. Logistics management provides greater efficiency, governance and compliance.